|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003191,
umls-concept:C0003873,
umls-concept:C0009429,
umls-concept:C0017710,
umls-concept:C0205210,
umls-concept:C0439858,
umls-concept:C0442108,
umls-concept:C0556895,
umls-concept:C0580822,
umls-concept:C1274040,
umls-concept:C1533685,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594,
umls-concept:C2603343
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-5-13
|
|
pubmed:abstractText |
To investigate whether clinical and radiographic disease control can be achieved and maintained in patients with early, active rheumatoid arthritis (RA) during the second year of aggressive treatment with conventional disease-modifying antirheumatic drugs (DMARDs) and intra-articular corticosteroid. This paper presents the results of the second year of the randomised, controlled double-blind CIMESTRA (Ciclosporine, Methotrexate, Steroid in RA) study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1468-2060
|
|
pubmed:author |
pubmed-author:ØstergaardMM,
pubmed-author:AndersenL SLS,
pubmed-author:CIMESTRA study group,
pubmed-author:EllingsenTT,
pubmed-author:Hørslev-PetersenKK,
pubmed-author:HansenG V OGV,
pubmed-author:HansenII,
pubmed-author:HetlandM LML,
pubmed-author:JunkerPP,
pubmed-author:JurikA GAG,
pubmed-author:LauridsenU BUB,
pubmed-author:LindegaardHH,
pubmed-author:LottenburgerTT,
pubmed-author:PedersenJ KJK,
pubmed-author:SkjødtHH,
pubmed-author:Stengaard-PedersenKK,
pubmed-author:SvendsenAA,
pubmed-author:TasaEE,
pubmed-author:VestergaardAA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
815-22
|
|
pubmed:meshHeading |
pubmed-meshheading:17878209-Adult,
pubmed-meshheading:17878209-Aged,
pubmed-meshheading:17878209-Antirheumatic Agents,
pubmed-meshheading:17878209-Arthritis, Rheumatoid,
pubmed-meshheading:17878209-Arthrography,
pubmed-meshheading:17878209-Betamethasone,
pubmed-meshheading:17878209-Combined Modality Therapy,
pubmed-meshheading:17878209-Cyclosporine,
pubmed-meshheading:17878209-Disease Progression,
pubmed-meshheading:17878209-Drug Therapy, Combination,
pubmed-meshheading:17878209-Female,
pubmed-meshheading:17878209-Glucocorticoids,
pubmed-meshheading:17878209-Humans,
pubmed-meshheading:17878209-Hydroxychloroquine,
pubmed-meshheading:17878209-Immunosuppressive Agents,
pubmed-meshheading:17878209-Injections, Intra-Articular,
pubmed-meshheading:17878209-Male,
pubmed-meshheading:17878209-Methotrexate,
pubmed-meshheading:17878209-Middle Aged,
pubmed-meshheading:17878209-Severity of Illness Index,
pubmed-meshheading:17878209-Statistics, Nonparametric,
pubmed-meshheading:17878209-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
|
|
pubmed:affiliation |
Department of Rheumatology, Copenhagen University Hospital, Hvidovre, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
